These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15288171)

  • 1. Heart failure clinics have decreased mortality and hospitalisation rates in Sweden.
    Strömberg A; Dahlström U
    Eur Heart J; 2004 Aug; 25(15):1368-9; author reply 1368. PubMed ID: 15288171
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart failure hospitalisations and deaths in New Zealand: patterns by deprivation and ethnicity.
    Riddell T
    N Z Med J; 2004 Jan; 118(1208):U1254. PubMed ID: 15682203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic heart failure: structural and functional deficit of our health policy?].
    Brutsaert DL
    Verh K Acad Geneeskd Belg; 2004; 66(3):173-82. PubMed ID: 15315118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why should we care about CARE-HF?
    Ellenbogen KA; Wood MA; Klein HU
    J Am Coll Cardiol; 2005 Dec; 46(12):2199-203. PubMed ID: 16360046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality from heart failure in an English population, 1979-2003: study of death certification.
    Goldacre MJ; Mant D; Duncan M; Griffith M
    J Epidemiol Community Health; 2005 Sep; 59(9):782-4. PubMed ID: 16100317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of left bundle branch block on long-term mortality in a population with heart failure.
    Tabrizi F; Englund A; Rosenqvist M; Wallentin L; Stenestrand U
    Eur Heart J; 2007 Oct; 28(20):2449-55. PubMed ID: 17670760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity and mortality in liver diseases in Sweden 1969-2001 in relation to alcohol consumption.
    Stokkeland K; Brandt L; Ekbom A; Osby U; Hultcrantz R
    Scand J Gastroenterol; 2006 Apr; 41(4):459-64. PubMed ID: 16635915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable impact of combining fatal and nonfatal end points in heart failure trials.
    Skali H; Pfeffer MA; Lubsen J; Solomon SD
    Circulation; 2006 Nov; 114(21):2298-303. PubMed ID: 17116781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in mortality after acute myocardial infarction with mild to moderate heart failure.
    Konstantino Y; Chen E; Hasdai D; Boyko V; Battler A; Behar S; Haim M
    Acute Card Care; 2007; 9(1):43-7. PubMed ID: 17453538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of death in patients with systolic heart failure.
    Patel J; Heywood JT
    J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):127-36. PubMed ID: 17562783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry.
    Shafazand M; Schaufelberger M; Lappas G; Swedberg K; Rosengren A
    Eur Heart J; 2009 Mar; 30(6):671-8. PubMed ID: 19109351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of heart rate variability footprint and standard deviation of average 5-minute intrinsic R-R intervals for mortality in cardiac resynchronization therapy patients.
    Gilliam FR; Singh JP; Mullin CM; McGuire M; Chase KJ
    J Electrocardiol; 2007 Oct; 40(4):336-42. PubMed ID: 17320897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How many patients admitted for heart failure are eligible for cardiac resynchronization therapy? Analysis of the Andalusian Heart Failure Registry (RAIC) study].
    García-Pinilla JM; Jiménez-Navarro MF; Anguita-Sánchez M; Martínez-Martínez A; Torres-Calvo F;
    Rev Esp Cardiol; 2007 Jan; 60(1):38-44. PubMed ID: 17288954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of current and investigational pharmacologic agents for acute heart failure syndromes.
    Shin DD; Brandimarte F; De Luca L; Sabbah HN; Fonarow GC; Filippatos G; Komajda M; Gheorghiade M
    Am J Cardiol; 2007 Jan; 99(2A):4A-23A. PubMed ID: 17239703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital cost effect of a heart failure disease management program: the Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial.
    Gregory D; Kimmelstiel C; Perry K; Parikh A; Konstam V; Konstam MA
    Am Heart J; 2006 May; 151(5):1013-8. PubMed ID: 16644325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study.
    Cleland JG; Louis AA; Rigby AS; Janssens U; Balk AH;
    J Am Coll Cardiol; 2005 May; 45(10):1654-64. PubMed ID: 15893183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of mortality and morbidity in patients with chronic heart failure.
    Pocock SJ; Wang D; Pfeffer MA; Yusuf S; McMurray JJ; Swedberg KB; Ostergren J; Michelson EL; Pieper KS; Granger CB
    Eur Heart J; 2006 Jan; 27(1):65-75. PubMed ID: 16219658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extending the horizon in chronic heart failure: effects of multidisciplinary, home-based intervention relative to usual care.
    Inglis SC; Pearson S; Treen S; Gallasch T; Horowitz JD; Stewart S
    Circulation; 2006 Dec; 114(23):2466-73. PubMed ID: 17116767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis for South Asian and white patients with heart failure in the United Kingdom: counterintuitive findings on heart failure in South Asians may be artefactual.
    Bhopal R; Fischbacher C
    BMJ; 2003 Dec; 327(7428):1405-6; author reply 1406. PubMed ID: 14670902
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for mortality and hospital re-admission after surgical ventricular restoration.
    Sartipy U; Albåge A; Lindblom D
    Eur J Cardiothorac Surg; 2006 Nov; 30(5):762-9. PubMed ID: 17027277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.